You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 146 No. 7, July 1986 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Editor's Correspondence
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Sodium Nitroprusside Treatment in Patients With Acute Strokes-Reply

Patrick Lavin, MB, BCh
Nashville, Tenn

Arch Intern Med. 1986;146(7):1454.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

—Dr Garner makes three valid points that I will deal with in turn.

  1. Sodium nitroprusside is not ideal, but should be the agent of choice because it is a powerful and predictably effective agent, without a direct effect on the central nervous system, and does not cause patchy ischemia.1 It is currently favored by most experts in the field.2-5 Its capacity to cause raised intracranial pressure is not clearly established.6,7 Diazoxide, used in small frequent boluses, and {alpha}-blockers, are also effective agents. However, newer agents such as captopril8 and the calcium channel blockers9 may prove more ideal.
  2. The point that hydralazine hydrochloride caused neurologic deterioration as a result of raised intracranial pressure is well taken, however, the patient did not exhibit signs of raised

  1. intracranial pressure; the computed tomographic scan showed no mass effect, and the neurologic deficit improved on raising the blood pressure. Trimethaphan camsylate, a good drug but
. . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.